Download Free Sample Report

This report contains market size and forecasts of Drugs for Hormonal Replacement Therapy in Global, including the following market information:

• Global Drugs for Hormonal Replacement Therapy Market Revenue, 2018-2023, 2023-2030, ($ millions)
• Global top five companies in 2022 (%)

The global Drugs for Hormonal Replacement Therapy market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Estrogen Replacement Therapy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Drugs for Hormonal Replacement Therapy include Novartis AG, Bayer AG, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company, Abbott, Mylan Laboratories, Merck & Co. and Hisamitsu Pharmaceutical Co. Inc., etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drugs for Hormonal Replacement Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Hormonal Replacement Therapy Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Drugs for Hormonal Replacement Therapy Market Segment Percentages, by Type, 2022 (%)

• Estrogen Replacement Therapy
• Human Growth Hormone Replacement Therapy
• Thyroid Replacement Therapy
• Testosterone Replacement Therapy

Global Drugs for Hormonal Replacement Therapy Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Drugs for Hormonal Replacement Therapy Market Segment Percentages, by Application, 2022 (%)

• Hypothyroidism
• Male Hypogonadism
• Growth Hormone Deficiency
• Menopause
• Others

Global Drugs for Hormonal Replacement Therapy Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Drugs for Hormonal Replacement Therapy Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Drugs for Hormonal Replacement Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies Drugs for Hormonal Replacement Therapy revenues share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis AG
• Bayer AG
• Pfizer Inc.
• Novo Nordisk A/S
• Eli Lilly and Company
• Abbott
• Mylan Laboratories
• Merck & Co.
• Hisamitsu Pharmaceutical Co. Inc.
• Teva Pharmaceutical Industries Ltd.
• F.Hoffmann-La Roche
• Noven Pharmaceuticals Inc.
• Orion Pharma AB
• Allergan Plc.
• QuatRx Pharmaceuticals
• Wyeth
• Amgen Inc.
• Roche
• Genentech
• TherapeuticsMD